home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

A Possible Explanation For Maternal Tolerance

  November, 9 2001 1:36
your information resource in human molecular genetics

Exasperated parents may facetiously wonder: 'why don't we kick our kids out?' In fact, that very question has perplexed immunologists for decades! Embryos developing within the womb express antigens from their father that are foreign to the mother's immune system, yet unlike any other graft of foreign tissue, they are not rejected. Chrousos and colleagues report a possible explanation for maternal tolerance in the November issue of Nature Immunology.

Embryo implantation in the uterus, which occurs very early in pregnancy, resembles a localized inflammatory lesion. Mothers who experience recurrent early miscarriages fail to control these immune reactions to their offspring. Researchers at the National Institute of Child Health and Human Development and the University of Crete, Greece, report that production of corticotrophin-releasing hormone (CRH; a hormone released by both the developing early embryo and the maternal endometrium that envelops the womb) induces the expression of a "cell suicide" signal called FasL. When activated lymphocytes, a potential threat to the developing embryo, engage FasL, they are triggered to die. Thus, rejection of the developing embryo by maternal lymphocytes is prevented by the protective FasL shield. Blocking CRH diminished embryo implantation and reduced the number of successful pregnancies. Thus, a potential cause for infertility in women may be due to a lack of CRH to inhibit immune reactions to their fetus.

Author contact:
George Chrousos
Pediatric and Reproductive Endocrinology Branch, National Institute of Child Health and Human Development, NIH
Bethesda, USA
Tel: +1 301 496 5800; E-mail chrousog@mail.nih.go

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.